InMode Ltd. (INMD) Spending and interest coverage
- R&D / revenue · 12 months: Value 3.59%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 3.00%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 3.59% | Research and development expense / revenue. Period ending 2025-12-31. $13.32M ÷ $370.50M × 100 ≈ 3.59% |
| Stock-based compensation / revenue · 12 months | 3.00% | Share-based compensation / revenue. Period ending 2025-12-31. $11.13M ÷ $370.50M × 100 ≈ 3.00% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 13.32M USD | Research and Development Expense |
| Revenue | 370.50M USD | |
| Stock-based compensation | 11.13M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 85.39M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $13.32M | $370.50M | $11.13M | $85.39M | (m) | 3.59% | 3.00% | (m) | (m) |
| 2024-12-31 | $13.14M | $394.82M | $16.57M | $112.53M | (m) | 3.33% | 4.20% | (m) | (m) |
| 2023-12-31 | $13.41M | $492.05M | $23.60M | $195.66M | (m) | 2.73% | 4.80% | (m) | (m) |
| 2022-12-31 | $12.43M | $454.27M | $24.45M | $197.85M | (m) | 2.74% | 5.38% | (m) | (m) |
| 2021-12-31 | $9.53M | $357.56M | $11.96M | $167.48M | (m) | 2.67% | 3.35% | (m) | (m) |
| 2020-12-31 | $9.47M | $206.11M | $12.85M | $72.84M | (m) | 4.59% | 6.23% | (m) | (m) |
| 2019-12-31 | $5.70M | $156.36M | $1.56M | $59.62M | (m) | 3.64% | 1.00% | (m) | (m) |
| 2018-12-31 | $4.18M | $100.16M | $1.95M | $23.49M | (m) | 4.17% | 1.94% | (m) | (m) |
| 2017-12-31 | $2.58M | $53.46M | $2.44M | $8.95M | (m) | 4.82% | 4.56% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.